Pope; Laura E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pope; Laura E..The latest application filed is for "pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders".

Company Profile

2.4.14

Pope; Laura E. - Carlsbad CA
Pope; Laura E. - Cartsbad CA
Pope, Laura E. - Calle Madrid Carlsbad CA
Pope, Laura E - Carlsbad CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20200276185 - Yakatan; Gerald ; et al.	2020-09-03
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20190201391 - YAKATAN; Gerald ; et al.	2019-07-04
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20180098984 - YAKATAN; Gerald ; et al.	2018-04-12
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20160287576 - Yakatan; Gerald ; et al.	2016-10-06
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20150209347 - Yakatan; Gerald ; et al.	2015-07-30
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20140288114 - Yakatan; Gerald ; et al.	2014-09-25
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20140045880 - Yakatan; Gerald ; et al.	2014-02-13
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20130072517 - YAKATAN; Gerald ; et al.	2013-03-21
Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders App 20120165363 - YAKATAN; Gerald ; et al.	2012-06-28
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20100137352 - YAKATAN; Gerald ; et al.	2010-06-03
Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders Grant 7,659,282 - Yakatan , et al. February 9, 2	2010-02-09
Pharmaceutical Compositions Comprising Dextromethorphan And Quinidine For The Treatment Of Neurological Disorders App 20090082384 - Yakatan; Gerald ; et al.	2009-03-26
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs Grant 7,091,190 - Marcelletti , et al. August 15, 2	2006-08-15
Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders App 20050203125 - Yakatan, Gerald ; et al.	2005-09-15
Viral inhibition by n-docosanol App 20040033982 - Katz, David H ; et al.	2004-02-19
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs App 20030073651 - Marcelletti, John F. ; et al.	2003-04-17
Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition Grant 5,952,392 - Katz , et al. September 14, 1	1999-09-14
Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols Grant 5,948,822 - Pope , et al. September 7, 1	1999-09-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.